Atea Pharmaceuticals, Inc. (AVIR) Market Cap
- 2026-09-03: Market Cap $467.19M.
- 2026-08-10: Market Cap $402.63M.
- 2026-06-30: Market Cap $372.95M.
- 2026-05-11: Market Cap $432.95M.
Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.
- Available history
- 2020-12-10 to 2026-09-03
- Data captured
Historical Market Cap
| Date | Market Cap |
|---|
| 2026-09-03 | $467.19M |
|---|
| 2026-08-10 | $402.63M |
|---|
| 2026-06-30 | $372.95M |
|---|
| 2026-05-11 | $432.95M |
|---|
| 2026-03-31 | $430.55M |
|---|
| 2026-03-04 | $396.77M |
|---|
| 2025-12-31 | $278.91M |
|---|
| 2025-11-10 | $260.16M |
|---|
| 2025-09-30 | $226.57M |
|---|
| 2025-08-04 | $280.13M |
|---|
| 2025-06-30 | $292.09M |
|---|
| 2025-05-09 | $232.78M |
|---|
| 2025-03-31 | $255.88M |
|---|
| 2025-03-04 | $248.02M |
|---|
| 2024-12-31 | $282.95M |
|---|
| 2024-11-04 | $282.95M |
|---|
| 2024-09-30 | $282.95M |
|---|
| 2024-08-07 | $276.06M |
|---|
| 2024-06-30 | $279.44M |
|---|
| 2024-05-13 | $340.26M |
|---|
| 2024-03-31 | $340.26M |
|---|
| 2024-02-25 | $353.49M |
|---|
| 2023-12-31 | $254.48M |
|---|
| 2023-11-07 | $279.51M |
|---|
| 2023-09-30 | $250.31M |
|---|
| 2023-08-05 | $289.4M |
|---|
| 2023-06-30 | $311.91M |
|---|
| 2023-05-05 | $279.39M |
|---|
| 2023-03-31 | $279.39M |
|---|
| 2023-02-25 | $305.86M |
|---|
| 2022-12-31 | $400.61M |
|---|
| 2022-11-04 | $503.06M |
|---|
| 2022-09-30 | $473.91M |
|---|
| 2022-08-05 | $731.84M |
|---|
| 2022-06-30 | $591.13M |
|---|
| 2022-05-05 | $467.91M |
|---|
| 2022-03-31 | $601.12M |
|---|
| 2022-02-25 | $530.15M |
|---|
| 2021-12-31 | $742.94M |
|---|
| 2021-11-10 | $886.71M |
|---|
| 2021-09-30 | $2.91B |
|---|
| 2021-08-10 | $2.72B |
|---|
| 2021-06-30 | $1.78B |
|---|
| 2021-05-13 | $1.59B |
|---|
| 2021-03-31 | $5.11B |
|---|
| 2021-03-29 | $4.85B |
|---|
| 2020-12-31 | $3.44B |
|---|
| 2020-12-10 | $2.34B |
|---|